Bodisen Biotech Inc (BBCZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,370 | -2,310 | -4,170 | 371 | -6,919 |
| Depreciation Amortization | 1,695 | 1,833 | 925 | 819 | 519 |
| Accounts receivable | -30 | 89 | -3,803 | 714 | -1,469 |
| Accounts payable and accrued liabilities | -175 | -591 | 1,154 | -639 | -513 |
| Other Working Capital | 462 | -3,062 | -98 | 582 | 11,803 |
| Other Operating Activity | 12,349 | 1,225 | 5,271 | -1,767 | 2,740 |
| Operating Cash Flow | $-2,069 | $-2,817 | $-722 | $80 | $6,162 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -13 | -559 | -15 | -9,182 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -307 |
| Other Investing Activity | 1,437 | 155 | -1,479 | 4,667 | 2,258 |
| Investing Cash Flow | $1,421 | $142 | $-2,038 | $4,652 | $-6,924 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 1,479 | N/A | N/A |
| Debt Issued | 1,425 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,426 | -155 | 0 | 0 | 0 |
| Financing Cash Flow | $-1 | $-155 | $1,479 | $N/A | $N/A |
| Exchange Rate Effect | 9 | 90 | 132 | 2 | 236 |
| Beginning Cash Position | 935 | 3,675 | 4,824 | 91 | 617 |
| End Cash Position | 295 | 935 | 3,675 | 4,824 | 91 |
| Net Cash Flow | $-641 | $-2,740 | $-1,149 | $4,733 | $-527 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,069 | -2,817 | -722 | 80 | 6,162 |
| Capital Expenditure | -16 | -13 | -559 | -15 | -9,182 |
| Free Cash Flow | -2,085 | -2,830 | -1,281 | 64 | -3,020 |